Ayaan Parikh LinkedIn · Jul 2026
Founder post on the V2 diligence release, citing 150+ V1 customers and introducing proprietary decision data.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
AI-maximalist pharma platform that sources, evaluates, and packages overlooked drug assets with an agent stack; currently licenses modular products and runs pilots, with a long-term plan to acquire, develop, and sell assets.
Primary product
AI-native drug sourcing and diligence platform (CAS + CDD).
Founded
2025
Headquarters
1395 22nd St, San Francisco, CA 94107
Team size
1-10
Work style
Remote
Industry
Biotechnology Research
Sub-industry
AI drug discovery / pharma diligence platform
Offices
1395 22nd St, San Francisco, CA 94107 (HQ)
Open Positions
0 jobs at Convexia
No open positions
Check back later for new openings